Clinical Trial Update: Outpatient Cervical Ripening With Orally Administered Misoprostol in Diabetics [NA]

View source ↗

Summary

A terminated clinical trial studied outpatient cervical ripening with orally administered misoprostol in pregnant individuals with gestational diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus Type 1 or 2 During Pregnancy
• Gestational Diabetes Mellitus

Drugs mentioned

• MISOPROSTOL (Misoprostol)

Snippet

Sponsor: MemorialCare Health System | Conditions: Diabetes, Gestational | NA | Status: TERMINATED | Results posted: 2023-10-23